Stocks
Celcuity Inc.CELC
NASDAQHealthcareBiotechnology$114.22+3.11%
A clinical-stage biotechnology company focused on developing targeted therapies for cancer driven by specific molecular pathways. Its lead program, gedatolisib, is being studied in late-stage trials for hormone receptor–positive, HER2‑negative breast cancer, targeting the PI3K/AKT/mTOR signaling pat...
Market Cap: $5.3B52W Range: $7.58 – $120.31
Congressional Interest in Celcuity Inc. (CELC)
1 member of Congress has disclosed 4 trades in Celcuity Inc. (CELC), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
1
Buys
3
Sells
1
Who in Congress Is Trading CELC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-05-26 | Tom Malinowski | sell | $1K – $15K |
| 2020-06-23 | Tom Malinowski | buy | $1K – $15K |